Astec LifeSciences Limited (BOM:533138)
India · Delayed Price · Currency is INR 602.70
+1.50 (0.25%)
At close: Aug 21, 2026
Astec LifeSciences Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Astec LifeSciences stock has a consensus rating of "Hold" and an average price target of ₹670.00. The average 1-year stock price forecast is 11.17% higher than the current stock price, while the lowest is ₹600.00 (-0.45%) and the highest is ₹740.00 (+22.78%).
Price Target: ₹670.00 (+11.17%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Astec LifeSciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
5.60B
from 4.48B
Increased by 24.85%
Revenue Next Year
7.41B
from 5.60B
Increased by 32.42%
EPS This Year
-12.50
from -36.81
EPS Next Year
11.00
from -12.50
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.